Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed

In this retrospective study, we investigated whether the kinetic change of serum carcinoembryonic antigen (CEA) levels can be an early indicator for the progression in metastatic non-small cell lung cancer (NSCLC) patients during maintenance therapy with bevacizumab plus pemetrexed. Ten patients dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasha, Zhang, Li, Kong, Fang, Shi, Wang, Jing, Haiyong, Wang, Ming, Yang, Jinming, Yu, Hui, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650388/
https://www.ncbi.nlm.nih.gov/pubmed/29088833
http://dx.doi.org/10.18632/oncotarget.20456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650388/
https://www.ncbi.nlm.nih.gov/pubmed/29088833
http://dx.doi.org/10.18632/oncotarget.20456

Ejemplares similares